C07C 39/28
The halogen being one chlorine atom
Official title: the halogen being one chlorine atom
C07C39/28 (The halogen being one chlorine atom) appears on 9 US grants and 8 published applications in this corpus.
Search patents in C07C- Granted patents
- 9
- Published applications
- 8
- Assignees
- 6
- Inventors
- 18
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- FXR (NR1H4) modulating compounds29 Aug 2023US 11,739,065 B2Gilead Sciences, Inc.
- FXR (NR1H4) modulating compounds20 Apr 2021US 10,981,881 B2Gilead Sciences, Inc.
- FXR (NR1H4) modulating compounds15 Sep 2020US 10,774,054 B2Gilead Sciences, Inc.
- FXR (NR1H4) modulating compounds24 Sep 2019US 10,421,730 B2Gilead Sciences, Inc.
- 2,5-dialkyl-4-H/halo/ether-phenol compounds25 Apr 2017US 9,630,896 B2Tansna Therapeutics, Inc.
- Synthetic Cannabinoid Compounds, Pharmaceutical Compositions, and Treatment Methods31 Oct 2024US 2024/0360061 A1Miralogx LLC
- Fxr (nr1h4) modulating compounds30 Jun 2022US 2022/0204460 A1Gilead Sciences, Inc.
- Fxr (nr1h4) modulating compounds26 Nov 2020US 2020/0369632 A1Gilead Sciences, Inc.
- Fxr (nr1h4) modulating compounds5 Mar 2020US 2020/0071282 A1Gilead Sciences, Inc.
- FXR (NR1H4) Modulating Compounds10 Oct 2019US 2019/0308962 A1Gilead Sciences, Inc.
Most cited
By later US patents
- FXR (NR1H4) modulating compounds8US 10,981,881 B2Gilead Sciences, Inc. · 2021
- Leukotriene antagonists and a method of use there as6US 4,764,521 AEli Lilly and Company · 1988
- FXR (NR1H4) modulating compounds3US 10,421,730 B2Gilead Sciences, Inc. · 2019
- [4H]-1,3-Benzodioxin-2-carboxylic acids2US 4,281,012 ARoussel Uclaf · 1981
- FXR (NR1H4) modulating compounds1US 10,774,054 B2Gilead Sciences, Inc. · 2020